Molecule That Binds to Tau and Works as Tracer Might Help to Diagnose and Treat Alzheimer’s, Study Reports

Molecule That Binds to Tau and Works as Tracer Might Help to Diagnose and Treat Alzheimer’s, Study Reports
A newly identified "tracer" molecule that binds to and "lights up" aggregates of tau — a protein linked to Alzheimer's disease and related dementias – showed promise as a way to diagnose Alzheimer's and measure the effectiveness of treatment in patients, researchers reported. The study, “First in‐human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948,” was published in The Journal of Nuclear Medicine. Alzheimer's disease is characterized by the presence of abnormal protein aggregates — amyloid plaques and tau tangles — in the brain. A hurdle in diagnosin
Subscribe or to access all post and page content.

One comment

Leave a Comment

Your email address will not be published. Required fields are marked *